21 /100
LOW RISK
Score updated Jul 13, 2026

SVA — Sinovac Biotech Ltd. Dilution Risk Tracker

Track SVA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SVA — Get alerts when the score changes →

As of July 13, 2026, Sinovac Biotech Ltd. (SVA) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Sinovac Biotech Ltd. has 71.86M shares outstanding, 29 institutional holders tracked. Key dilution vectors include approximately 140 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
34
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SVA.
🔔 Track SVA — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding71.86M
FloatN/A
Cash$5.97B
Debt$498.18M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 56.4% shares (2026Q1 vs prior)
29 institutional holders · 16.42M shares
#1 Vivo Capital, LLC 11.81M shares
#2 ORBIMED ADVISORS LLC 2.72M shares
#3 RENAISSANCE TECHNOLOGIES LLC 1.31M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest82.2K
Days to Cover1000.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for SVA Shareholders

Sinovac Biotech Ltd. (SVA) has a DilutionScore of 21/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for SVA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SVA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SVA alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SVA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SVA
📊 SVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SVA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.